Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxycodone + acetaminophen is a fixed-dose combination oral analgesic used to relieve moderate to severe pain when opioid treatment is necessary and other pain medicines are inadequate or not tolerated. Oxycodone is an opioid analgesic that acts on the central nervous system by binding to opioid receptors, reducing the transmission of pain signals in the brain and spinal cord. Acetaminophen is a non-opioid analgesic and antipyretic that works primarily by inhibiting prostaglandin synthesis in the central nervous system, thereby enhancing the effects of oxycodone. The combination provides synergistic pain relief but carries risks such as dependence, addiction (primarily due to oxycodone), respiratory depression, and potential liver toxicity at high doses or with prolonged use due to acetaminophen[1][3][4][5]. It is available only by prescription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxycodone + acetaminophen.